| Dr Ericha L Worple, DO | |
|
Iowa Specialty Hospital - Clarion, 1316 S Main St, Clarion, IA 50525-2019 | |
| (515) 532-2811 | |
| (319) 343-1161 |
| Full Name | Dr Ericha L Worple |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 9 Years |
| Location | Iowa Specialty Hospital - Clarion, Clarion, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205227865 | NPI | - | NPPES |
| 1205227865 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | DO-05636 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Trinity Regional Medical Center | Fort dodge, IA | Hospital |
| Iowa Specialty Hospital - Belmond | Belmond, IA | Hospital |
| Humboldt County Memorial Hospital | Humboldt, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Belmond Community Hospital | 1052201852 | 66 |
| Iowa Physicians Clinic Medical Foundation | 8729992318 | 972 |
News Archive
A proof-of-concept, phase 2 trial by an international research team has found promising results for a myostatin antibody in treating the decline in muscle mass and power associated with aging.
The Guardian examines China's one-child policy and its impact. The newspaper writes that "the description of the system as a 'one-child policy' is misleading. Most married women in China have the chance to bear two offspring, but the entitlement to breed beyond a solitary child is determined by a complex set of rules" and factors.
Noting "[t]his week leaders from around the world convened in Ireland for the Dublin Conference on Hunger, Nutrition and Climate Justice," Kanika Bahl, a managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog,
Young men with low levels of aerobic fitness are more likely to have albuminuria or glomerular hyperfiltration, both early signs of chronic kidney disease, than those with higher levels of fitness.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the bevacizumab (Genentech/Roche/Chugai's Avastin)/paclitaxel (Bristol-Myers Squibb's Taxol, generics)/carboplatin (Bristol-Myers Squibb's Paraplatin, generics) regimen will remain Decision Resources' proprietary clinical gold standard for the treatment of advanced non-small-cell lung cancer through 2018.
› Verified 5 days ago
| Entity Name | Iowa Physicians Clinic Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366425274 PECOS PAC ID: 8729992318 Enrollment ID: O20031118000363 |
News Archive
A proof-of-concept, phase 2 trial by an international research team has found promising results for a myostatin antibody in treating the decline in muscle mass and power associated with aging.
The Guardian examines China's one-child policy and its impact. The newspaper writes that "the description of the system as a 'one-child policy' is misleading. Most married women in China have the chance to bear two offspring, but the entitlement to breed beyond a solitary child is determined by a complex set of rules" and factors.
Noting "[t]his week leaders from around the world convened in Ireland for the Dublin Conference on Hunger, Nutrition and Climate Justice," Kanika Bahl, a managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog,
Young men with low levels of aerobic fitness are more likely to have albuminuria or glomerular hyperfiltration, both early signs of chronic kidney disease, than those with higher levels of fitness.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the bevacizumab (Genentech/Roche/Chugai's Avastin)/paclitaxel (Bristol-Myers Squibb's Taxol, generics)/carboplatin (Bristol-Myers Squibb's Paraplatin, generics) regimen will remain Decision Resources' proprietary clinical gold standard for the treatment of advanced non-small-cell lung cancer through 2018.
› Verified 5 days ago
| Entity Name | Iowa Specialty Hospital- Clarion |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396760153 PECOS PAC ID: 3375451347 Enrollment ID: O20031120000622 |
News Archive
A proof-of-concept, phase 2 trial by an international research team has found promising results for a myostatin antibody in treating the decline in muscle mass and power associated with aging.
The Guardian examines China's one-child policy and its impact. The newspaper writes that "the description of the system as a 'one-child policy' is misleading. Most married women in China have the chance to bear two offspring, but the entitlement to breed beyond a solitary child is determined by a complex set of rules" and factors.
Noting "[t]his week leaders from around the world convened in Ireland for the Dublin Conference on Hunger, Nutrition and Climate Justice," Kanika Bahl, a managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog,
Young men with low levels of aerobic fitness are more likely to have albuminuria or glomerular hyperfiltration, both early signs of chronic kidney disease, than those with higher levels of fitness.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the bevacizumab (Genentech/Roche/Chugai's Avastin)/paclitaxel (Bristol-Myers Squibb's Taxol, generics)/carboplatin (Bristol-Myers Squibb's Paraplatin, generics) regimen will remain Decision Resources' proprietary clinical gold standard for the treatment of advanced non-small-cell lung cancer through 2018.
› Verified 5 days ago
| Entity Name | Belmond Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821122623 PECOS PAC ID: 1052201852 Enrollment ID: O20040316001360 |
News Archive
A proof-of-concept, phase 2 trial by an international research team has found promising results for a myostatin antibody in treating the decline in muscle mass and power associated with aging.
The Guardian examines China's one-child policy and its impact. The newspaper writes that "the description of the system as a 'one-child policy' is misleading. Most married women in China have the chance to bear two offspring, but the entitlement to breed beyond a solitary child is determined by a complex set of rules" and factors.
Noting "[t]his week leaders from around the world convened in Ireland for the Dublin Conference on Hunger, Nutrition and Climate Justice," Kanika Bahl, a managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog,
Young men with low levels of aerobic fitness are more likely to have albuminuria or glomerular hyperfiltration, both early signs of chronic kidney disease, than those with higher levels of fitness.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the bevacizumab (Genentech/Roche/Chugai's Avastin)/paclitaxel (Bristol-Myers Squibb's Taxol, generics)/carboplatin (Bristol-Myers Squibb's Paraplatin, generics) regimen will remain Decision Resources' proprietary clinical gold standard for the treatment of advanced non-small-cell lung cancer through 2018.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ericha L Worple, DO 1316 S Main St, Clarion, IA 50525-2019 Ph: (515) 602-9833 | Dr Ericha L Worple, DO Iowa Specialty Hospital - Clarion, 1316 S Main St, Clarion, IA 50525-2019 Ph: (515) 532-2811 |
News Archive
A proof-of-concept, phase 2 trial by an international research team has found promising results for a myostatin antibody in treating the decline in muscle mass and power associated with aging.
The Guardian examines China's one-child policy and its impact. The newspaper writes that "the description of the system as a 'one-child policy' is misleading. Most married women in China have the chance to bear two offspring, but the entitlement to breed beyond a solitary child is determined by a complex set of rules" and factors.
Noting "[t]his week leaders from around the world convened in Ireland for the Dublin Conference on Hunger, Nutrition and Climate Justice," Kanika Bahl, a managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog,
Young men with low levels of aerobic fitness are more likely to have albuminuria or glomerular hyperfiltration, both early signs of chronic kidney disease, than those with higher levels of fitness.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the bevacizumab (Genentech/Roche/Chugai's Avastin)/paclitaxel (Bristol-Myers Squibb's Taxol, generics)/carboplatin (Bristol-Myers Squibb's Paraplatin, generics) regimen will remain Decision Resources' proprietary clinical gold standard for the treatment of advanced non-small-cell lung cancer through 2018.
› Verified 5 days ago
Dr. Mark Henry Andrew, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1316 S Main St, Clarion, IA 50525 Phone: 515-532-2811 Fax: 515-532-9336 | |
Dr. Bhoompally Reddy, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1316 S Main St, Clarion, IA 50525 Phone: 515-532-2811 |